4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
14.70
-0.24 (-1.61%)
At close: Sep 3, 2026, 4:00 PM EDT
14.52
-0.18 (-1.22%)
After-hours: Sep 3, 2026, 6:02 PM EDT
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 196 employees as of December 31, 2025. The number of employees decreased by 31 or -13.66% compared to the previous year.
Employees
196
Change (1Y)
-31
Growth (1Y)
-13.66%
Revenue / Employee
$469,429
Profits / Employee
-$914,158
Market Cap
812.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 196 | -31 | -13.66% |
| Dec 31, 2024 | 227 | 80 | 54.42% |
| Jun 30, 2024 | 201 | 64 | 46.72% |
| Mar 31, 2024 | 171 | 34 | 24.82% |
| Dec 31, 2023 | 147 | 7 | 5.00% |
| Sep 30, 2023 | 144 | 4 | 2.86% |
| Jun 30, 2023 | 137 | -1 | -0.72% |
| Mar 31, 2023 | 137 | 0 | - |
| Dec 31, 2022 | 140 | 16 | 12.90% |
| Sep 30, 2022 | 140 | 19 | 15.70% |
| Jun 30, 2022 | 138 | 34 | 32.69% |
| Mar 31, 2022 | 137 | 49 | 55.68% |
| Dec 31, 2021 | 124 | 41 | 49.40% |
| Sep 30, 2021 | 121 | 43 | 55.13% |
| Jun 30, 2021 | 104 | 26 | 33.33% |
| Mar 31, 2021 | 88 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| DBV Technologies | 170 |
| Aura Biosciences | 113 |
| Cybin | 100 |
| Theravance Biopharma | 90 |
| CytomX Therapeutics | 69 |
| Crescent Biopharma | 69 |
| Climb Bio | 29 |
FDMT News
- 9 days ago - 4DMT to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 17 days ago - B. Riley views EyePoint study miss as positive for 4D Molecular - TheFly
- 18 days ago - 4D Molecular price target lowered to $32 from $33 at Goldman Sachs - TheFly
- 20 days ago - 4DMT Announces New Employment Inducement Grants - GlobeNewsWire
- 21 days ago - 4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewsWire
- 21 days ago - 4D Molecular Therapeutics Quarterly report: Q2 2026 - Filings
- 21 days ago - 4D Molecular Therapeutics Earnings release: Q2 2026 - Filings
- 4 weeks ago - 4D Molecular initiated with a Buy at B. Riley - TheFly